Investing.com - Financial Markets Worldwide
📈 69% of S&P 500 stocks beating the index - a historic record! Pick the best ones with AI.See top stocks

Royalty Pharma Plc (RPRX)

NASDAQ
Symbol
Exchange
Currency
RPRXNASDAQUSD
RPDGTradeGateEUR
Currency in USD
Disclaimer
27.57
-0.18(-0.65%)
Closed
After Hours
27.52-0.05(-0.18%)

RPRX Cash Flow Statement

Advanced Cash Flow Statement
Collapse All
Period Ending:
2017
31/12
2018
31/12
2019
31/12
2020
31/12
2021
31/12
2022
31/12
2023
31/12
Cash from Operations
aa.aaaa.aaaa.aaaa.aaaa.aa2,143.982,987.8
Cash from Operations Growth
Net Income
Depreciation & Amortisation, Total
Amortisation of Deferred Charges, Total
Other Non-Cash Items, Total
Change in Net Operating Assets
Cash from Investing
aa.aaaa.aaaa.aaaa.aaaa.aa-1,029.42-2,072.79
Cash from Investing Growth
Capital Expenditure
Sale of Property, Plant, and Equipment
Cash Acquisitions
Divestitures
Other Investing Activities
Cash from Financing
aa.aaaa.aaaa.aaaa.aaaa.aa-944.86-2,148.75
Cash from Financing Growth
Total Debt Issued
Short Term Debt Issued, Total
Long-Term Debt Issued, Total
Total Debt Repaid
Short Term Debt Repaid, Total
Long-Term Debt Repaid, Total
Issuance of Common Stock
Repurchase of Common Stock
Issuance of Preferred Stock
Repurchase of Preferred Stock
Common & Preferred Stock Dividends Paid
Special Dividend Paid
Other Financing Activities
Foreign Exchange Rate Adjustments
Miscellaneous Cash Flow Adjustments
Net Change in Cash
aa.aaaa.aaaa.aaaa.aaaa.aa169.7-1,233.74
Beginning Cash Balance
Ending Cash Balance
Levered Free Cash Flow
Levered Free Cash Flow Growth
Free Cash Flow Yield
* In Millions of USD (except for per share items)